High SVR achieved in decompensated HCV patients with 12-week therapy

SAN FRANCISCO – In patients infected with hepatitis C virus (HCV) who have decompensated liver disease, a 12-week combination drug regimen with velpatasvir and sofosbuvir (VEL/SOF) with or without...